arrow
B

Brian L. West

daiichi sankyo company limited
H指数:70
被引数:2.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Phase 1b/2 study of orally administered pexidartinib in combination with radiation therapy and temozolomide in patients with newly diagnosed glioblastoma
2024-11-220
OAAI
Microglia modulate blood flow, neurovascular coupling, and hypoperfusion via purinergic actions

小胶质细胞通过嘌呤能作用调节血流,神经血管耦合和灌注不足

2022-02-24109
OAAI
A phase 1/2 study of the oral FLT3 inhibitor pexidartinib in relapsed/refractory FLT3-ITD-mutant acute myeloid leukemia

口服FLT3抑制剂pexidartinib治疗复发/难治性FLT3-ITD-mutant急性髓系白血病的1/2期研究

2020-04-2433
OAAI
Sustained microglial depletion with CSF1R inhibitor impairs parenchymal plaque development in an Alzheimer's disease model
2019-08-21574
OAAI
Phase Ib study of the combination of pexidartinib (PLX3397), a CSF-1R inhibitor, and paclitaxel in patients with advanced solid tumors

晚期实体瘤患者CSF-1R抑制剂pexidartinib (PLX3397) 和紫杉醇联合治疗的Ib期研究

2019-06-21102
OAAI
The RUNX1/IL-34/CSF-1R axis is an autocrinally regulated modulator of resistance to BRAF-V600E inhibition in melanoma
2018-07-2531
OA
Microglia control the spread of neurotropic virus infection via P2Y12 signalling and recruit monocytes through P2Y12-independent mechanisms
2018-07-19119
OAAI
Microglia ablation alleviates myelin-associated catatonic signs in mice
2017-12-1886
OA